SCHEMBL8555588

SCHEMBL8555588

CCCc1[nH]c2cc(C(=O)OC)cc(Cc3ccccc3Cl)c2c1C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
PPARG P37231 4/20 0.44
PPARA Q07869 4/20 0.44
ALOX5 P09917 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ATM Q13315 1/20 0.43
PTGES O14684 1/20 0.41
GPR84 Q9NQS5 1/20 0.38
POLB P06746 1/20 0.36
TSHR P16473 2/20 0.35
HSP90AA1 P07900 1/20 0.35
KIF11 P52732 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551585 0.91 SMN1; SMN2 (0.48) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL8554409 0.89 LMNA (0.47) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL8553605 0.82 ALOX5 (0.48) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL251645 0.82 ALOX5 (0.43) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL8551933 0.81 PDE3B (0.51) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL7424550 0.79 ALOX5 (0.39) SMN1; SMN2LMNAPDE3BPDE3AALOX5
SCHEMBL8551838 0.78 LMNA (0.55) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL8557469 0.78 PDE3B (0.52) SMN1; SMN2LMNAPDE3BPDE3APPARG
SCHEMBL8554263 0.78 ALOX5 (0.39) SMN1; SMN2LMNAPDE3BPDE3AALOX5
SCHEMBL8551861 0.78 ALOX5 (0.41) SMN1; SMN2LMNAPDE3BPDE3AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed